These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 9886435)

  • 1. Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors.
    Antonysamy MA; Fanslow WC; Fu F; Li W; Qian S; Troutt AB; Thomson AW
    J Immunol; 1999 Jan; 162(1):577-84. PubMed ID: 9886435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cells genetically engineered to express IL-4 exhibit enhanced IL-12p70 production in response to CD40 ligation and accelerate organ allograft rejection.
    Kaneko K; Wang Z; Kim SH; Morelli AE; Robbins PD; Thomson AW
    Gene Ther; 2003 Jan; 10(2):143-52. PubMed ID: 12571643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft.
    Buonocore S; Flamand V; Goldman M; Braun MY
    Transplantation; 2003 Feb; 75(3):407-13. PubMed ID: 12589166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that an OX-2-positive cell can inhibit the stimulation of type 1 cytokine production by bone marrow-derived B7-1 (and B7-2)-positive dendritic cells.
    Gorczynski L; Chen Z; Hu J; Kai Y; Lei J; Ramakrishna V; Gorczynski RM
    J Immunol; 1999 Jan; 162(2):774-81. PubMed ID: 9916698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.
    Lu L; Li W; Fu F; Chambers FG; Qian S; Fung JJ; Thomson AW
    Transplantation; 1997 Dec; 64(12):1808-15. PubMed ID: 9422424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival.
    Liang X; Lu L; Chen Z; Vickers T; Zhang H; Fung JJ; Qian S
    Transplantation; 2003 Aug; 76(4):721-9. PubMed ID: 12973117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-12p40-overexpressing immature dendritic cells induce T cell hyporesponsiveness in vitro but accelerate allograft rejection in vivo: role of NK cell activation and interferon-gamma production.
    Sun W; He X; Guo Z; Wang Q; Li X; Rayner J; Zhang L; Wang J; Cao X
    Immunol Lett; 2004 Jul; 94(3):191-9. PubMed ID: 15275966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infusion of stably immature monocyte-derived dendritic cells plus CTLA4Ig modulates alloimmune reactivity in rhesus macaques.
    Zahorchak AF; Kean LS; Tokita D; Turnquist HR; Abe M; Finke J; Hamby K; Rigby MR; Larsen CP; Thomson AW
    Transplantation; 2007 Jul; 84(2):196-206. PubMed ID: 17667811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethanol affects the generation, cosignaling molecule expression, and function of plasmacytoid and myeloid dendritic cell subsets in vitro and in vivo.
    Lau AH; Abe M; Thomson AW
    J Leukoc Biol; 2006 May; 79(5):941-53. PubMed ID: 16478920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of interleukin-4 on the phenotype and function of bone marrow-derived murine dendritic cells generated under serum-free conditions.
    Wells JW; Darling D; Farzaneh F; Galea-Lauri J
    Scand J Immunol; 2005 Mar; 61(3):251-9. PubMed ID: 15787742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation of dendritic cells in murine organ donors by Flt3 ligand alters the balance between transplant tolerance and immunity.
    Steptoe RJ; Fu F; Li W; Drakes ML; Lu L; Demetris AJ; Qian S; McKenna HJ; Thomson AW
    J Immunol; 1997 Dec; 159(11):5483-91. PubMed ID: 9548488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene transfer of soluble interleukin-17 receptor prolongs cardiac allograft survival in a rat model.
    Li J; Simeoni E; Fleury S; Dudler J; Fiorini E; Kappenberger L; von Segesser LK; Vassalli G
    Eur J Cardiothorac Surg; 2006 May; 29(5):779-83. PubMed ID: 16520057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
    Cai Y; Tang XD; Zhou PJ
    Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo administration of flt3 ligand markedly stimulates generation of dendritic cell progenitors from mouse liver.
    Drakes ML; Lu L; Subbotin VM; Thomson AW
    J Immunol; 1997 Nov; 159(9):4268-78. PubMed ID: 9379022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of recipient-derived dendritic cells to induce donor-specific T-cell hyporesponsiveness.
    Tiao MM; Lu L; Tao R; Harnaha J; Fung JJ; Huang LT; Qian S
    Transplant Proc; 2004 Jun; 36(5):1592-4. PubMed ID: 15251391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immunoadhesin incorporating the molecule OX-2 is a potent immunosuppressant that prolongs allo- and xenograft survival.
    Gorczynski RM; Cattral MS; Chen Z; Hu J; Lei J; Min WP; Yu G; Ni J
    J Immunol; 1999 Aug; 163(3):1654-60. PubMed ID: 10415071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion.
    Horibe EK; Sacks J; Unadkat J; Raimondi G; Wang Z; Ikeguchi R; Marsteller D; Ferreira LM; Thomson AW; Lee WP; Feili-Hariri M
    Transpl Immunol; 2008 Feb; 18(4):307-18. PubMed ID: 18158116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of intestinal Peyer's patch interferon-alpha producing (plasmacytoid) dendritic cells.
    Castellaneta A; Abe M; Morelli AE; Thomson AW
    Hum Immunol; 2004 Feb; 65(2):104-13. PubMed ID: 14969765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free bone graft attenuates acute rejection and in combination with cyclosporin a leads to indefinite cardiac allograft survival.
    Wang H; Ge W; Arp J; Zassoko R; Liu W; Ichim TE; Jiang J; Jevnikar AM; Garcia B
    J Immunol; 2009 May; 182(10):5970-81. PubMed ID: 19414748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-13 prolongs allograft survival: association with inhibition of macrophage cytokine activation.
    Davidson C; Verma ND; Robinson CM; Plain KM; Tran GT; Hodgkinson SJ; Hall BM
    Transpl Immunol; 2007 Apr; 17(3):178-86. PubMed ID: 17331844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.